News
U.S. Senator Maggie Hassan said on Friday she is launching an investigation into British pharmaceutical giant GlaxoSmithKline's decision to discontinue a widely used asthma inhaler for children.
Veterans Affairs data-based study finds that changing from MDI to DPI is linked to greater healthcare use, though the veteran ...
Manufacturer GSK announced earlier this year that it’s discontinuing its branded inhaler Flovent HFA and Flovent Diskus on Dec. 31, and introduced “authorized" generic versions.
But going green may have some inhaler users seeing red, as the ozone-friendly inhalers cost miore. Epinephrine inhalers go for around $20. The alternatives, which contain the drug albuterol, cost ...
Asthma inhaler to be discontinued in January – here's what patients should know. By Kelly Hayes. Updated December 28, 2023 6:11am PST Health Care. KTVU FOX 2 San Francisco article ...
HFA inhalers must be used differently than the old-fashioned kind. The medicine feels and tastes different, sometimes alarming new users despite doctors' assurances that it works just as well.
Flovent — a common asthma inhaler — will be discontinued in 2024. There will be a generic version available, but the change could make it hard for some patients to get their medication.
Many users of a common asthma inhaler are poised to lose it in the new year, possibly due to changes to Medicaid rebate rules from the Biden administration. GSK, manufacturer of the popular ...
Flovent, a common asthma inhaler dating back to the 1990s, contains a corticosteroid that prevents asthma attacks by reducing inflammation in the airway.
Facing criticism over its pricing, Boehringer Ingelheim plans to cap out-of-pocket costs at $35 a month for its entire line of inhalers for asthma and COPD.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results